Glunova Biotech LLC

When you order a research peptide, a Certificate of Analysis (COA) should arrive with it — either inside the package or as a downloadable PDF linked to your lot number. Most researchers glance at the purity percentage and move on. That is a mistake. The COA contains eight or more distinct analytical fields, and misreading any of them can compromise your experimental data — or worse, introduce a contaminant that invalidates months of work.

This guide walks you through every section of a standard research peptide COA, explains what each value means scientifically, identifies the red flags that should stop you before reconstitution, and closes with a realistic walkthrough of a BPC-157 COA you can use as a reference template.

What a COA Is

A Certificate of Analysis is a formal quality document issued by the manufacturer or a third-party analytical laboratory that records the actual test results for a specific production lot of a substance. For research peptides, the COA certifies the analytical outcomes of that batch — purity, identity, physical appearance, and safety-relevant parameters like endotoxin content.

What a COA does not certify: it is not a safety clearance for human use, not a regulatory approval, and not a guarantee of biological activity in your specific model. It reports analytical chemistry data. Interpreting that data in the context of your research application is your responsibility as the investigator.

Every legitimate research peptide supplier issues lot-specific COAs. If a supplier provides a generic COA that applies to “all lots” of a compound rather than your specific lot number, that is a serious quality failure.

Anatomy of a COA

A complete research peptide COA contains the following sections. Some suppliers combine fields; others expand them. What matters is that the underlying data is present and traceable.

Header Block

The header identifies the product and lot. It should contain:

• Product name and synonym (e.g., BPC-157, Body Protection Compound-157)
• CAS number — for BPC-157: 137525-51-0
• Molecular formula — e.g., C62H98N16O22
• Molecular weight — e.g., 1419.55 g/mol
• Lot number — must be unique and traceable to a production record
• Manufacturing date
• Retest date (not “expiry” — peptides are typically assigned retest dates pending stability data)
• Quantity manufactured

Cross-reference the CAS number against a verified chemical database (PubChem, ChemSpider) to confirm you have the correct compound. Sequences can be scrambled; identity must be verified analytically, not assumed from the product name.

Appearance Section

Most research peptides are shipped as lyophilized (freeze-dried) powder. The appearance field should read something like: “White to off-white lyophilized powder.” Acceptable variation includes slightly yellowish tinge for copper-containing peptides (GHK-Cu) or slightly beige coloration depending on sequence composition.

Yellow-brown discoloration, visible clumping with moisture absorption, or crystalline appearance in a supposedly lyophilized product are all anomalies worth querying.

HPLC Purity Section

High-Performance Liquid Chromatography (HPLC) is the primary purity assay for research peptides. The COA should state:

• Method reference — e.g., “Reverse-phase HPLC, C18 column, gradient elution, UV detection at 220 nm”
• Purity result — expressed as area percentage of the main peak, e.g., “99.2%”
• Retention time — the time at which the main peak elutes under defined conditions
• Chromatogram reference or attachment

Research-grade peptides should achieve 98% HPLC purity minimum; many high-quality suppliers target 99%. The purity figure represents the percentage of the integrated chromatographic area attributable to the target peptide versus all detected impurities.

Mass Spectrometry Section

Mass spectrometry (MS) confirms molecular identity — that the molecule you have is actually the target peptide sequence, not a degradation product or synthesis impurity with coincidentally similar chromatographic behavior.

The COA should state:

• Method — ESI-MS (electrospray ionization) or MALDI-TOF (matrix-assisted laser desorption)
• Observed mass — the measured m/z value (typically [M+H]+ for ESI)
• Theoretical mass — calculated from the molecular formula
• Acceptance criterion — e.g., observed mass within 0.5 Da of theoretical, or within 0.1%

Endotoxin Section

Endotoxins (lipopolysaccharides from gram-negative bacterial cell walls) are a critical contamination risk in injectable research materials. Even at low concentrations they trigger severe inflammatory responses in animal models, confounding experimental results dramatically.

The COA should reference:

• Method — Limulus Amebocyte Lysate (LAL) assay per USP <85>
• Result — expressed as EU/mg (endotoxin units per milligram)
• Acceptance criterion — typically <1.0 EU/mg for research purposes; some applications specify <0.1 EU/mg

Sterility Section

Not all research peptide COAs include sterility testing, as lyophilized peptides for reconstitution are not always manufactured under aseptic conditions. If sterility is claimed, the COA should reference USP <71> method and provide a negative result for aerobic bacteria, anaerobic bacteria, and fungi.

If sterility testing is absent, this does not necessarily indicate a problem — it should be consistent with the supplier’s stated manufacturing conditions. Researchers working with in vivo models should clarify this with their supplier.

Water Content (Karl Fischer)

Lyophilized peptides retain a small percentage of residual water. The Karl Fischer titration method quantifies this. Typical result: 3-8% w/w. High water content (above 10%) may indicate incomplete lyophilization, which affects shelf life and means the actual peptide content per mass unit is lower than labeled.

This matters for concentration calculations: if you weigh 10 mg of a peptide with 5% water content, your actual peptide mass is approximately 9.5 mg — a non-trivial difference for precise dosing in quantitative research.

Heavy Metals

Expressed in parts per million (ppm), this section covers lead, cadmium, arsenic, and mercury at minimum. Acceptable limits vary by application; typical research-grade specifications are below 10 ppm total heavy metals per ICH Q3D guidance.

QA Signature Block

A complete COA is signed by a Quality Assurance officer or designated laboratory representative. The signature block confirms that a qualified individual has reviewed and approved the results. An unsigned COA is analytically incomplete.

Red Flags to Watch For

These are the COA findings that should stop you before you proceed:

• HPLC purity below 95% — Research-grade peptides should meet 98% minimum. Below 95% indicates significant impurity content; below 90% is disqualifying for any rigorous research application.
• Missing lot number or generic lot designation — A COA labeled “Lot 1” or “Lot A” with no traceable identifier is not lot-specific documentation. This is a major quality control failure.
• No method references for HPLC or MS — Purity percentages without methodological context cannot be evaluated. What column? What mobile phase? What detection wavelength? These determine whether the result is meaningful.
• No QA signature — An unsigned COA has not been formally reviewed. It may be a generated report without human validation.
• Endotoxin above 5 EU/mg — This level will produce measurable inflammatory responses in standard animal models, confounding any in vivo experimental data.
• Retest date already passed — Peptides past their retest date have not been verified to meet specifications. They may still be within spec, but without confirmation testing, you cannot know.
• MS identity missing entirely — A COA with only HPLC purity and no mass confirmation leaves open the question of whether the correct molecule was synthesized. This is an incomplete analytical package.
• Mismatch between observed and theoretical mass exceeding 2 Da — Small discrepancies are expected from instrument calibration; large discrepancies suggest a different compound.

HPLC Purity: What 99% Actually Means

The purity percentage on an HPLC COA is an area percentage — the fraction of the total integrated chromatogram area accounted for by the main peak. It is not a weight percentage of peptide versus all other compounds in the vial.

This distinction matters because HPLC area percentage only measures compounds that are UV-detectable at the chosen wavelength and that elute within the chromatographic run window. Non-UV-absorbing compounds, very early-eluting species, or compounds that do not interact with the column stationary phase may not be captured.

Common sources of HPLC impurities in research peptides include:

• Oxidized variants — methionine-containing peptides are particularly susceptible to oxidation at the sulfur atom, producing +16 Da adducts
• Deletion sequences — incomplete synthesis products missing one or more amino acid residues; these are common in solid-phase peptide synthesis (SPPS) of long sequences
• Scrambled disulfide bonds — for cysteine-containing peptides, incorrect disulfide pairing produces conformationally distinct impurities that may not be biologically active
• Racemization products — particularly at aspartate and cysteine residues; L to D conversion produces diastereomers with altered biological properties
• TFA (trifluoroacetic acid) salts — residual counterion from HPLC purification; not detected as an impurity peak but contributes to vial mass

For most research applications — cell culture assays, receptor binding studies, in vitro mechanistic work — 98% HPLC purity is appropriate. For in vivo pharmacokinetic studies where dose precision matters, 99% is the professional standard. For crystallography or NMR structural work, researchers sometimes require 99.5%.

Mass Spec: Why Identity Matters

A peptide with 99.5% HPLC purity is still analytically incomplete without mass spectrometry identity confirmation. HPLC tells you what percentage of the detected UV signal comes from the main peak — it does not tell you whether the main peak is the correct molecule.

In practice, synthesis failures occasionally produce a dominant product that elutes cleanly from HPLC but is not the target sequence. Scrambled sequences, C-terminally modified variants, or protecting-group retention artifacts can all present as sharp, dominant HPLC peaks.

ESI-MS (electrospray ionization mass spectrometry) is the standard identity confirmation method for research peptides. For a peptide with molecular weight M, you expect to observe [M+H]+ (singly charged, m/z = M+1.008), [M+2H]2+ (doubly charged, m/z = (M+2×1.008)/2), and potentially [M+3H]3+ for larger peptides. All observed charge states should correspond to the theoretical molecular weight of the target sequence.

MALDI-TOF is an alternative method — simpler sample preparation, higher throughput, but less precise for larger peptides (above 3000 Da) and more susceptible to salt adducts. Either method is acceptable; the key requirement is that the result is reported with observed vs. theoretical mass and an explicit acceptance criterion.

When to Request a Stability Study Report

The retest date on a COA is derived from stability data — accelerated or real-time stability studies conducted by the manufacturer at defined storage conditions. Standard freeze-dried peptide specifications typically set retest periods of 24-36 months at -20°C storage based on stability data.

You should request a stability study report (separate from the COA) when:

• Your research timeline extends past the lot’s retest date and you need to confirm continued specification compliance
• Your peptide will be stored under non-standard conditions (e.g., -80°C for extended aliquot storage, or controlled room temperature transit)
• You have experienced a temperature excursion during shipping and need to assess degradation risk
• Your application requires freeze-thaw stability data (e.g., multiple reconstitution cycles in an ongoing study)

A stability study report will show time-point HPLC purity data, typically at 0, 3, 6, 12, 18, and 24 months. Look for the degradation rate — if purity is declining rapidly between time points, the compound has poor intrinsic stability. For most well-synthesized peptides stored correctly, the decline between months 0 and 24 should be less than 1% absolute HPLC purity.

Freeze-thaw data matters when you are reconstituting large batches and storing aliquots. A standard protocol tests 3-5 freeze-thaw cycles at defined conditions and measures HPLC purity and potency retention after each cycle.

Sample COA Walkthrough: BPC-157 Lot BPC2026-04A

The following is a realistic fictional COA walkthrough using BPC-157 as the example compound. Values are representative of a high-quality research peptide lot.

This COA passes all critical checkpoints: unique traceable lot number, high HPLC purity with method reference, confirmed MS identity within 0.01 Da, endotoxin well below research thresholds, complete QA authorization, and a retest date two years out. This is the standard Glunova Biotech LLC ships with every lot.

Request a Sample COA

Qualified research institutions and laboratory purchasing teams can request sample COAs for any compound in our catalog before placing an order. We provide lot-specific COAs including HPLC chromatograms, ESI-MS spectra, and endotoxin LAL results.